Mackenzie Financial Corp Sells 12,437 Shares of Encompass Health Co. (NYSE:EHC)

Mackenzie Financial Corp lowered its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 24.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 38,302 shares of the company's stock after selling 12,437 shares during the quarter. Mackenzie Financial Corp's holdings in Encompass Health were worth $3,537,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. PharVision Advisers LLC acquired a new stake in Encompass Health in the 4th quarter valued at approximately $572,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Encompass Health by 18.4% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 367,598 shares of the company's stock valued at $33,948,000 after buying an additional 57,130 shares during the last quarter. Woodline Partners LP grew its holdings in Encompass Health by 44.5% in the 4th quarter. Woodline Partners LP now owns 184,473 shares of the company's stock valued at $17,036,000 after buying an additional 56,817 shares during the last quarter. Squarepoint Ops LLC grew its holdings in Encompass Health by 599.0% in the 4th quarter. Squarepoint Ops LLC now owns 127,204 shares of the company's stock valued at $11,747,000 after buying an additional 109,007 shares during the last quarter. Finally, Twinbeech Capital LP acquired a new stake in Encompass Health in the 4th quarter valued at approximately $3,893,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Insider Activity at Encompass Health

In related news, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the transaction, the executive vice president now directly owns 79,710 shares of the company's stock, valued at approximately $9,149,910.90. This represents a 11.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider now directly owns 11,958 shares of the company's stock, valued at $1,394,422.38. This trade represents a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 132,663 shares of company stock valued at $16,034,082. Insiders own 2.00% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on EHC. KeyCorp raised their target price on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday. Barclays raised their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday, April 25th. William Blair reiterated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Wall Street Zen upgraded Encompass Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, May 24th. Finally, Royal Bank of Canada upped their target price on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research report on Monday, April 28th. Eight investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $122.71.

Encompass Health Stock Up 0.8%

Shares of NYSE:EHC traded up $1.00 during mid-day trading on Friday, reaching $121.01. 977,100 shares of the stock were exchanged, compared to its average volume of 702,178. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The company has a market cap of $12.20 billion, a P/E ratio of 27.13, a P/E/G ratio of 2.31 and a beta of 0.91. Encompass Health Co. has a one year low of $82.74 and a one year high of $122.09. The stock's 50 day simple moving average is $109.93 and its 200-day simple moving average is $102.01.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Encompass Health's quarterly revenue was up 10.6% on a year-over-year basis. During the same period last year, the company earned $1.12 earnings per share. As a group, equities research analysts predict that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a yield of 0.56%. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.